The Aperlena Verdict
Open raceNo supplier dominates: 23 different companies have won the last 28 comparable contracts from this buyer over 5 years. This is a genuinely open race.
- Expected final price vs the published estimate
- 0%
Based on 28 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.
Summary
Machine-generated summaryIKK classic, a German statutory health insurer, announces that it will conclude non-exclusive discount agreements with all interested and suitable pharmaceutical companies for various active substances and active substance combinations under Section 130a (8) SGB V, on identical, non-negotiable terms in an open-house procedure. The contract period runs from 01.09.2025 to 31.08.2027, with the Omalizumab lot starting on 01.10.2025. The earliest contract start is 01.09.2025 if signed documents are submitted by 05.08.2025, and 01.10.2025 for Omalizumab if submitted by 10.09.2025. Joining remains possible at any time until 05.07.2027. Listed active ingredients include Abatacept, Atovaquone, Beclometasone and Formoterol, Betaine, Brinzolamide and Brimonidine, Certolizumab pegol, Colesevelam, Etravirine, immunoglobulins and Melatonin.
Key points
Original text
Bid or no-bid?
Six questions before you commit a team. Under each one, what the register holds on it. The answers are yours.
Can I bid?
- Open procedure: any interested supplier may submit a bid. Above the EU threshold: open to companies from any EU country.
- The notice is written in German.
- Certificates from another EU country? Check the equivalents on eCertis
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Report an error in this notice
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 4 days ago
What this buyer has paid before
Based on 18 comparable contracts this buyer awarded in this sector over the last 4 years.
- Median award
- €1
- Middle half of past awards
- €1 to €1
TED - Tenders Electronic Daily (Publications Office of the EU) publishes no value for this notice, so it has no mark on the scale. The official documents may state one.
Most recent awards
- Arzneimittel - Abschluss eines nicht-exklusiven Rabattvertrages gemäß §§ 130a Abs. 8 und 130c Abs. 1 SGB V zwischen der IKK classic und der Purpose Pharma AB zu Attrogy
- Arzneimittel - Abschluss eines nicht-exklusiven Rabattvertrages gemäß §§ 130a Abs. 8 und 130c Abs. 1 SGB V zwischen der IKK classic und der GlaxoSmithKline GmbH & Co. KG zu Exdensur
- Arzneimittel - Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130c Abs. 1 SGB V zwischen der IKK classic und der hcd medical GmbH zu Vabysmo
- Arzneimittel - Arzneimittelausschreibung 2026_vergebene Aufträge €224,584,123
- Arzneimittel - Arzneimittelausschreibung 2026_vergebene Aufträge €224,584,123
Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.
The buyer
Full buyer profileIKK classic
- notices in the register
- 129
- awards
- 59
- awarded in total
- €624.8M
Who wins its contracts
Many suppliers- different companies won its awards
- 52
- of the awards went to the three most frequent winners
- 12%
- of its calls state an estimated value
- 5%
Based on 57 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.
Competition
- tenders per lot on average (open and restricted procedures)
- 4.4
- of those lots received a single tender
- 13%
- of the awards went to companies based in another country
- 12%
As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.
One dot per award, on the day it was signed, sized by its value. A ring is an award with no published value.
Who usually wins this buyer's contracts in this sector
Based on 28 awards with a linked company profile over the last 5 years.
20 open tenders right now
Market context
TED - Tenders Electronic Daily (Publications Office of the EU) publishes no value for this notice, so it cannot be placed among the open notices of its sector. The official documents may state one.
- open now in Medical equipment & pharmaceuticals
- 10,824
- median open notice
- €144,479
Who wins in this market
Many suppliersGermany · Medical equipment & pharmaceuticals
- different companies won awards here
- 811
- of the awards went to the three most frequent winners
- 9%
- buyers awarded contracts here
- 443
Based on 1,514 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.
Competition
- tenders per lot on average (open and restricted procedures)
- 12.2
- of those lots received a single tender
- 16%
- of the awards went to companies based in another country
- 7%
- of the tenders came from another country
- 6%
As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.
Similar tenders
Open now
Awarded before
Never miss a tender like this
1,812 new notices in Medical equipment & pharmaceuticals in Germany in the last 7 days. Get an email when new ones appear. Free.
Set up my alert